Recent work has demonstrated that expression of type 1 fimbriae is represse
d by PapB, a regulator of pyelonephritis-associated pili (P-pili). PapB bel
ongs to family of related adhesin regulators, for which consensus residues
required for DNA binding and oligomerization have been identified. Of the r
egulators tested in this study, PapB, SfaB (S-fimbriae) and PefB (Salmonell
a enterica serovar Typhimurium plasmid-encoded fimbriae) repressed FimB-pro
moted off-to-on inversion of the fim switch, although complete repression w
as only demonstrated by PapB. DaaA, FaeB, FanA, FanB and ClpB had no effect
on fim switching. In addition, only PapB stimulated FimE-promoted on-to-of
f inversion. Deletion analysis demonstrated that this specificity resides i
n the carboxy terminal of the protein, and not the amino terminal, with the
central region being homologous among the family members. Exchange of Leu(
82) and Ile(83) of PapB for the equivalent residues from the DaaA protein (
Phe and Gin) within the carboxy terminal virtually abolished cross-talk act
ivity. Whereas PapB can bind to a region around the left inverted repeat of
the fim switch, DaaA and the PapB double mutant were effectively unable to
bind this region. A previously characterized PapB DNA binding mutant also
failed to bind to this region and failed to inhibit FimB activity at the fi
m switch. Thus, repression of fim expression appears unique to PapB and Sfa
B within E. coli and requires DNA binding involving amino acid residues loc
ated both within the homologous core and in the heterogeneous carboxy termi
nus. The variation in the carboxy terminus between the PapB family members
explains their differential effects on fim. This mechanism of cross-talk se
ems restricted to the P and S family adhesins with type 1 fimbriae and may
ensure variable and sequential expression of adhesins during urinary tract
infections.